MA46898A - Compositions pour la conservation d'organes - Google Patents
Compositions pour la conservation d'organesInfo
- Publication number
- MA46898A MA46898A MA046898A MA46898A MA46898A MA 46898 A MA46898 A MA 46898A MA 046898 A MA046898 A MA 046898A MA 46898 A MA46898 A MA 46898A MA 46898 A MA46898 A MA 46898A
- Authority
- MA
- Morocco
- Prior art keywords
- compositions
- organ conservation
- conservation
- organ
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title 1
- 210000000056 organ Anatomy 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N1/00—Preservation of bodies of humans or animals, or parts thereof
- A01N1/02—Preservation of living parts
- A01N1/0205—Chemical aspects
- A01N1/021—Preservation or perfusion media, liquids, solids or gases used in the preservation of cells, tissue, organs or bodily fluids
- A01N1/0226—Physiologically active agents, i.e. substances affecting physiological processes of cells and tissue to be preserved, e.g. anti-oxidants or nutrients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
- A61K31/138—Aryloxyalkylamines, e.g. propranolol, tamoxifen, phenoxybenzamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C211/00—Compounds containing amino groups bound to a carbon skeleton
- C07C211/01—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms
- C07C211/02—Compounds containing amino groups bound to a carbon skeleton having amino groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C211/03—Monoamines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/30—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| HUP1600639 | 2016-11-24 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MA46898A true MA46898A (fr) | 2019-10-02 |
Family
ID=89720188
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MA046898A MA46898A (fr) | 2016-11-24 | 2017-11-24 | Compositions pour la conservation d'organes |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20190335745A1 (fr) |
| EP (1) | EP3544420B8 (fr) |
| CN (1) | CN110337244B (fr) |
| CA (1) | CA3044746A1 (fr) |
| DK (1) | DK3544420T3 (fr) |
| ES (1) | ES2926179T3 (fr) |
| HU (1) | HUE060027T2 (fr) |
| IL (1) | IL266833B (fr) |
| MA (1) | MA46898A (fr) |
| PL (1) | PL3544420T3 (fr) |
| WO (1) | WO2018096376A1 (fr) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2015138832A1 (fr) | 2014-03-13 | 2015-09-17 | The General Hospital Corporation | Dispositifs et des méthodes pour améliorer et évaluer la viabilité de foies humains |
| WO2022241417A1 (fr) * | 2021-05-10 | 2022-11-17 | The General Hospital Corporation | Méthodes et compositions pour prolonger la conservation d'un organe et d'un tissu |
Family Cites Families (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3692835A (en) | 1967-04-05 | 1972-09-19 | Jan Van Dijk | Pharmacologically active amino-ethyl oximes |
| NL7503312A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| NL7503309A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| NL7503310A (nl) | 1975-03-20 | 1976-09-22 | Philips Nv | Verbindingen met antidepressieve werking. |
| US4083978A (en) | 1976-01-27 | 1978-04-11 | Egyt Gyogyszervegyeszeti Gyar | Oxime ethers |
| US5086054A (en) | 1990-07-31 | 1992-02-04 | Sri International | Novel arylcycloalkanepolyalkylamines |
| US6297212B1 (en) * | 1994-05-31 | 2001-10-02 | Gregory M. Fahy | Growth hormone therapy and related methods and pharmaceutical compositions |
| IN184685B (fr) * | 1996-02-14 | 2000-09-23 | Nat Inst Immunology | |
| IN186677B (fr) | 1999-11-12 | 2001-10-20 | Sun Pharmaceutical Ind Ltd | |
| US8765364B2 (en) * | 2007-05-18 | 2014-07-01 | Lifeline Scientific, Inc. | Ex vivo methods for validating substance testing with human organs and/or tissues |
| RU2460525C2 (ru) * | 2008-01-04 | 2012-09-10 | Эл Джи Лайф Сайенсиз Лтд. | Производные индола и индазола, обладающие консервирующим действием по отношению к клеткам, тканям и органам |
| SE533552C2 (sv) * | 2008-12-30 | 2010-10-26 | Igeloesa Transplantation Science Ab | Förfarande och lösning för behandling av en potentiell organdonator |
| US8906919B2 (en) * | 2009-07-09 | 2014-12-09 | Ozteo Pty Ltd | Treatment of non-neuronal and non-myocardial cell, tissue and organ damage and associated pain with persistent sodium current blockers |
| EP2353598A1 (fr) | 2010-02-04 | 2011-08-10 | Laboratorios Del. Dr. Esteve, S.A. | Ligands sigma pour utilisation dans la prévention et/ou le traitement de la douleur post-opératoire |
| US20130018059A1 (en) * | 2010-03-31 | 2013-01-17 | Abela Pharmaceuticals, Inc. | Dimethyl sulfoxide (dmso) formulations for treating autism |
| SE534862C2 (sv) * | 2010-05-14 | 2012-01-24 | Vivoline Medical Ab | Användning av en medicinsk vätska för behandling av ett uttaget organ |
| US9333205B2 (en) * | 2010-07-30 | 2016-05-10 | Nerviano Medical Sciences S.R.L. | Isoxazolo-quinazolines as modulators of protein kinase activity |
| EP2763526A4 (fr) * | 2011-10-03 | 2015-06-03 | Vivoline Medical Ab | Fluide médical comprenant une globuline et son utilisation pour la conservation d'organes collectés |
| EP3104847B8 (fr) * | 2014-02-07 | 2020-12-30 | Támogatott Kutatócsoportok Irodája | Nouvelle utilisation de composés agonistes du récepteur sigma-1 |
| CN104292126B (zh) * | 2014-08-14 | 2016-08-24 | 广东东阳光药业有限公司 | 萘衍生物及其在药物上的应用 |
| US20170295776A1 (en) * | 2016-04-18 | 2017-10-19 | University Of Cincinnati | Red blood cell storage solutions, solution additives, and methods for improving the storage of red blood cells |
-
2017
- 2017-11-24 MA MA046898A patent/MA46898A/fr unknown
- 2017-11-24 ES ES17829007T patent/ES2926179T3/es active Active
- 2017-11-24 US US16/463,944 patent/US20190335745A1/en active Pending
- 2017-11-24 CA CA3044746A patent/CA3044746A1/fr active Pending
- 2017-11-24 HU HUE17829007A patent/HUE060027T2/hu unknown
- 2017-11-24 CN CN201780084580.9A patent/CN110337244B/zh active Active
- 2017-11-24 DK DK17829007.8T patent/DK3544420T3/da active
- 2017-11-24 PL PL17829007.8T patent/PL3544420T3/pl unknown
- 2017-11-24 WO PCT/HU2017/050051 patent/WO2018096376A1/fr unknown
- 2017-11-24 EP EP17829007.8A patent/EP3544420B8/fr active Active
-
2019
- 2019-05-23 IL IL266833A patent/IL266833B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP3544420A1 (fr) | 2019-10-02 |
| ES2926179T3 (es) | 2022-10-24 |
| US20190335745A1 (en) | 2019-11-07 |
| CA3044746A1 (fr) | 2018-05-31 |
| IL266833A (en) | 2019-08-29 |
| CN110337244B (zh) | 2023-07-21 |
| CN110337244A (zh) | 2019-10-15 |
| HUE060027T2 (hu) | 2023-01-28 |
| DK3544420T3 (da) | 2022-09-05 |
| EP3544420B1 (fr) | 2022-06-22 |
| PL3544420T3 (pl) | 2022-11-21 |
| EP3544420B8 (fr) | 2022-11-23 |
| WO2018096376A1 (fr) | 2018-05-31 |
| IL266833B (en) | 2022-01-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MA44486A (fr) | Procédés d'intervention précoce pour prévenir ou atténuer la toxicité | |
| MA55629A (fr) | Compositions d'anticorps pour le traitement de tumeurs | |
| MA46652A (fr) | Polythérapie pour l'inhibition de c3 | |
| MA47460A (fr) | Aminotriazolopyridines utilisées en tant qu'inhibiteurs de kinase | |
| MA52004A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glycopyranosidase | |
| MA47420A (fr) | Composés inhibiteurs d'oga | |
| MA47736A (fr) | Pyrimidopyrimidinones utiles en tant qu'inhibiteurs de la kinase wee-1 | |
| FR3022462B1 (fr) | Composition orale d'anticorps anti-tnfalpha | |
| MA49006A (fr) | Inhibiteurs d'ip6k | |
| FR3016407B1 (fr) | Boitier d'entrainement pour equipements | |
| MA50787A (fr) | Compositions fongicides | |
| MA41116A (fr) | Compositions d'inhibiteur de trans-signalisation par l'il-6 sélectif | |
| MA45552A (fr) | Compositions destinées au traitement de l'amylose | |
| MA39500A (fr) | Compositions à base d'extraits de plantes pour l'inhibition de la 5-alpha-réductase | |
| MA50906A (fr) | Inhibiteurs d'immunoprotéasome | |
| FR3024138B1 (fr) | Composition de mortier pour enduit ou revetement d'interieur | |
| FR3020758B1 (fr) | Composition pour ameliorer l'hygiene buco-dentaire | |
| DK3609464T3 (da) | Xanthohumolbaserede sammensætninger | |
| MA46898A (fr) | Compositions pour la conservation d'organes | |
| FR3035775B1 (fr) | Composition attractive pour la bruche de la feverole | |
| MA53648A (fr) | Inhibiteurs d'o-glycoprotéine-2-acétamido-2-désoxy-3-d-glucopyranosidase | |
| FR3018897B3 (fr) | Structure lineaire encastrable pour l'illumination | |
| MA43764A (fr) | Inhibiteur monovalent de l'interaction hutnfr1 | |
| JP2019529462A5 (ja) | Ｔｎｆｒｓｆ １４抑制物質を含む皮膚美白用組成物 | |
| MA42048A (fr) | Dérivés d'aminoesters |